Interest in the possible metabolic effect of beverages continues following the release of recent research by Scientists at the Nestlé Institute of Health Sciences.
C&I WEEK contacted Nestlé Australia for comment on our recent story “Nestlé to unlock the metabolic ‘master switch’?” and have since been provided with the following infographic which explains how an enzyme called AMPK helps muscles turn glucose and fat into energy and how this metabolic master switch could be controlled to assist people with metabolic disorders.
In response to C&I WEEK’s questions Nestlé Australia has responded:
“We are in the early stages of research but have already been looking at the role and function of the AMPK enzyme for two years. We are quite some time away from considering the product application but the research to date by Nestlé Research, and others in this field, is promising.”
“The target audience for such an ingredient are those suffering from metabolic problems like obesity and chronic metabolic diseases, such as Type 2 diabetes, as well as those having difficulties remaining active due to lifestyle, old age or disability. These are increasing problems globally, including in Australia.”
“As this remains early stage research it would be premature to say exactly what kinds of products might be the right carriers for this ingredient.”